Patients Are Still ‘Nervous’ About Telehealth Technology

News
Video

An expert spoke with CURE® about telehealth when it comes to ostomies within patients with bladder cancer, and overall within patients and survivors.

Telehealth within cancer care has upsides for patients and survivors, such as flexible scheduling and minimal transportation. The cancer community can also communicate with their medical professionals easily due to the modernization of technology.

Telehealth can also be seen as more cost efficient to patients with cancer, due to transportation and travel bills. Appointments online with providers result in more affordable options within this population.

Read More: Telehealth Offers ‘Significantly Lower’ Costs for Rural Patients with Urologic Cancer

Dr. Robert Krause, professor of Surgery, University of Pennsylvania, spoke with CURE® to discuss the benefits of telehealth, alongside the fears that the cancer community have about its popularity.

Krause also discussed a recent study that had been conducted which focused on the improvement within quality of life for patients or survivors with bladder cancer. The study, which was conducted during pre-COVID, was able to use telehealth as an impactful tool throughout this time, as face-to-face interactions were rarely possible, especially within the patient population.

Transcript:

One would hope that people are less scared of it, as they have more experience. There are a lot of people who still are nervous about the technology. And obviously, it's typically more older people, not necessarily always, of course, and we hope over time that will lessen.

We found that for this particular study, we were able to improve fairly rapidly. And people were really, really excited about the technology. Technology may have added to people being more frank with each other, or more open. If you're sitting in a room and talking about very sensitive things that may be harder than when you're a little bit distant, and together. And so routinely, people talked about really sensitive things in the group, and really learned a lot from each other. And that was part of the goal. So the technology, I think, and also one of the things that I think was really helpful was there was from the University of Arizona and assigned engineer to help people monitor the technology, they tested ahead of time to make sure they got it, that they were on if there's any problems, they help them and I think it ease the burden for a lot of people, at least in the beginning to make sure they could actually do it, and that the technology was not scary.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Woman with dark brown hair and pink lipstick wearing a light pink blouse with a light brown blazer. Patients should have conversations with their providers about treatments after receiving diagnoses.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE